VERACHEM LLC

Germantown, MD · Biotech · Private

Computational platform for predicting metalloenzyme-ligand binding affinities using advanced molecular modeling

verachem.com →
Grants
$12M
15 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Statistical Mechanics with Quantum Potentials: Application to Host-Gues$746,434
Federal grantDepartment of Health and Human Services · Phase II · Statistical Mechanics with Quantum Potentials Application to Host Gues$2,215,762
Federal grantDepartment of Health and Human Services · Phase II · Statistical Mechanics with Quantum Potentials: Application to Host-Gues$734,664
Federal grantDepartment of Health and Human Services · Phase II · Statistical Mechanics with Quantum Potentials: Application to Host-Gues$734,664
Federal grantDepartment of Health and Human Services · Phase II · Statistical mechanics with quantum potentials: Application to protein-ligand binding affinities$216,588
Federal grantDepartment of Health and Human Services · Phase II · Statistical mechanics with quantum potentials: Application to protein-ligand binding affinities$1,419,746
Federal grantDepartment of Health and Human Services · Phase II · Statistical mechanics with quantum potentials: Application to protein-ligand binding affinities$715,223
Federal grantDepartment of Health and Human Services · Phase II · Statistical mechanics with quantum potentials: Application to protein-ligand binding affinities$704,523
Federal grantDepartment of Health and Human Services · Phase II · Covalent protein-ligand binding affinities with VM2$251,379
Federal grantDepartment of Health and Human Services · Phase II · Covalent protein-ligand binding affinities with VM2$835,166
Federal grantDepartment of Health and Human Services · Phase II · Covalent protein-ligand binding affinities with VM2$785,946
Federal grantDepartment of Health and Human Services · Phase II · Metalloenzyme binding affinity prediction with VM2$311,466
Federal grantDepartment of Health and Human Services · Phase I · Metalloenzyme binding affinity prediction with VM2$311,466
Federal grantDepartment of Health and Human Services · Phase II · Metalloenzyme binding affinity prediction with VM2$915,334
Federal grantDepartment of Health and Human Services · Phase II · Metalloenzyme binding affinity prediction with VM2$915,334
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1369Curebiotech, Inc.——
1370BOUND THERAPEUTICS LLC——
1371BioHybrid Solutions LLC——
1372VERACHEM LLC——
1373SARFEZ PHARMACEUTICALS, INC.——
1374KAPS BIOTECH, INC.——
1375LAUREN SCIENCES, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Fast Assignment Of Partial Atomic Chargesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.